Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad to Sell $300M in Senior Notes

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said today that it will raise $300 million through the sale of senior notes through a private offering.

The $300 million, which the company plans to use for general corporate purposes, working capital, and potentially for acquisitions, is an increase of $50 million over what the company said on Monday that it planned to receive from the sale.

Under the agreement, it will sell $300 million in aggregate principal of the 8 percent subordinated senior notes, which will be due in 2016.

Bio-Rad said that the notes "may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws."

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.